Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
Clinical trial NCT03869697 · COMPLETED
Trial details
- NCT number
- NCT03869697
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2021-11-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.